Invention Grant
- Patent Title: Universal donor cells
-
Application No.: US17383760Application Date: 2021-07-23
-
Publication No.: US11433103B2Publication Date: 2022-09-06
- Inventor: Alireza Rezania , Rebeca Ramos-Zayas
- Applicant: CRISPR THERAPEUTICS AG
- Applicant Address: CH Zug
- Assignee: CRISPR THERAPEUTICS AG
- Current Assignee: CRISPR THERAPEUTICS AG
- Current Assignee Address: CH Zug
- Agency: Polsinelli PC
- Main IPC: C07K14/74
- IPC: C07K14/74 ; A61K35/39 ; C12N5/074 ; C12N5/071 ; C12N5/10 ; C12N5/16 ; C12N5/0735

Abstract:
Genetically modified cells that are compatible with multiple subjects, e.g., universal donor cells, and methods of generating said genetic modified cells are provided herein. The universal donor cells comprise at least one genetic modification within or near at least one gene that encodes a survival factor, wherein the genetic modification comprises an insertion of a polynucleotide encoding a tolerogenic factor. The universal donor cells may further comprise at least one genetic modification within or near a gene that encodes one or more MHC-I or MHC-II human leukocyte antigens or a component or a transcriptional regulator of a MHC-I or MHC-II complex, wherein said genetic modification comprises an insertion of a polynucleotide encoding a second tolerogenic factor.
Public/Granted literature
- US20220016177A1 UNIVERSAL DONOR CELLS Public/Granted day:2022-01-20
Information query